Clinical Trials Browser

Approved for marketing × Pancreatic Neoplasms × Oxaliplatin × Clear all

NCT00786058 2009-06-15

A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003

Approved for marketing

Gastrointestinal

Pancreatic Neoplasms